Genetic engineering concept. Medical science. Scientific Laboratory.

LineaRx Achieves Higher Expression and Survival Rates in Human T Cells

Posted on

STONY BROOK, NY. April 29, 2019 – LineaRx, Inc. ( the “Company”) a wholly owned subsidiary of Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today that it has improved expression levels and survival rates of linear DNA constructs delivered without viruses or plasmids to human T cells. In collaboration with Avectas, a cell engineering technology […]

Read More email